Home Biosimilar Antibodies Neuronal Signaling Beta Amyloid antibody Bapineuzumab (Anti-Amyloid Beta) For research use only.
Not for use in humans.

Bapineuzumab (Anti-Amyloid Beta)

Synonyms: AAB-001

Bapineuzumab (Anti-Amyloid Beta) is a monoclonal antibody targeting β-amyloid protein (APP). It can be used for the research of Alzheimer’s disease (AD). MW :140.16 KD.

Bapineuzumab (Anti-Amyloid Beta)

Purity & Quality Control

Batch: A311101 Purity: 99% Protein concentration: 4.81mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Beta Amyloid Inhibitors

Biological Activity

Description Bapineuzumab (Anti-Amyloid Beta) is a monoclonal antibody targeting β-amyloid protein (APP). It can be used for the research of Alzheimer’s disease (AD). MW :140.16 KD.

Product Details

CAS No. 648895-38-9
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bapineuzumab (Anti-Amyloid Beta) | Bapineuzumab (Anti-Amyloid Beta) supplier | purchase Bapineuzumab (Anti-Amyloid Beta) | Bapineuzumab (Anti-Amyloid Beta) cost | Bapineuzumab (Anti-Amyloid Beta) manufacturer | order Bapineuzumab (Anti-Amyloid Beta) | Bapineuzumab (Anti-Amyloid Beta) distributor